Drug
NUTROF TOTAL
NUTROF TOTAL is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph not_applicable
3
60%
Ph phase_4
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_4
FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment
NCT04761341
completednot_applicable
Gastrointestinal Tolerance Assessment of T2309
NCT04596605
completednot_applicable
Investigation of the Genetic and Environmental Determinants of MP Including Response to Supplementation
NCT01778231
completednot_applicable
Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation
NCT01404845
completedphase_3
Lutein Influence on Macula of Persons Issued From Amd Parents
NCT01269697
Clinical Trials (5)
Showing 5 of 5 trials
NCT04761341Phase 4
FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment
NCT04596605Not Applicable
Gastrointestinal Tolerance Assessment of T2309
NCT01778231Not Applicable
Investigation of the Genetic and Environmental Determinants of MP Including Response to Supplementation
NCT01404845Not Applicable
Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation
NCT01269697Phase 3
Lutein Influence on Macula of Persons Issued From Amd Parents
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5